With devices becoming increasingly complex, competent authorities in the European Union must ensure there are sufficiently well-trained experts at notified body level, particularly for assessing innovative devices and for clinical trials. But authorities are facing difficult resource issues and finding experts is a real challenge...
Scrip Regulatory Affairs
EU must tackle clinical trials shortfalls as current lack of evidence is "appalling"
30 July 2010
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- Swedish objection letter criticises medtech quality system standard
- High-profile UK investigation lambasts EU device regulations and medtech companies
- European Commission jury still out over future legal framework for recast
- EU on track to demand publicly available product registration for all devices
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
